ATE376835T1 - Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis - Google Patents

Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis

Info

Publication number
ATE376835T1
ATE376835T1 AT02758008T AT02758008T ATE376835T1 AT E376835 T1 ATE376835 T1 AT E376835T1 AT 02758008 T AT02758008 T AT 02758008T AT 02758008 T AT02758008 T AT 02758008T AT E376835 T1 ATE376835 T1 AT E376835T1
Authority
AT
Austria
Prior art keywords
psoriasis
arthritis
fucanes
adhesion
treatment
Prior art date
Application number
AT02758008T
Other languages
English (en)
Inventor
John Jackson
Helen Burt
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE376835T1 publication Critical patent/ATE376835T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02758008T 2001-08-29 2002-08-29 Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis ATE376835T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29

Publications (1)

Publication Number Publication Date
ATE376835T1 true ATE376835T1 (de) 2007-11-15

Family

ID=23224048

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02758008T ATE376835T1 (de) 2001-08-29 2002-08-29 Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis

Country Status (15)

Country Link
US (3) US6812220B2 (de)
EP (1) EP1420801B1 (de)
JP (2) JP4758063B2 (de)
KR (2) KR100910246B1 (de)
CN (2) CN1319540C (de)
AT (1) ATE376835T1 (de)
AU (1) AU2002325113B2 (de)
CA (1) CA2458853C (de)
DE (1) DE60223262T2 (de)
DK (1) DK1420801T3 (de)
ES (1) ES2295386T3 (de)
MX (1) MXPA04001876A (de)
NZ (2) NZ547609A (de)
PT (1) PT1420801E (de)
WO (1) WO2003018033A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
WO2004027027A2 (en) * 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004078210A1 (ja) * 2003-03-06 2004-09-16 Takashi Muramatsu 開腹手術後の癒着の予防剤
EP1631265A2 (de) * 2003-05-30 2006-03-08 Arc Pharmaceuticals, Inc. Verwendung von verschiedenen wirkstoffen zur hemmung fibröser adhäsionen
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US20070238677A1 (en) * 2004-03-17 2007-10-11 Locomogene, Inc. Pharmaceutical Composition Containing Hshrd3
JP2008505716A (ja) * 2004-07-09 2008-02-28 ザ クリーヴランド クリニック ファウンデーション ヒドロキシフェニル架橋高分子ネットワーク及びその用途
PL1809303T3 (pl) 2004-09-23 2019-11-29 Arc Medical Devices Inc Kompozycje farmaceutyczne i sposoby dotyczące hamowania zrostów włóknistych lub stanów zapalnych przy użyciu fukanów o niskiej zawartości siarczanów
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
KR100752244B1 (ko) * 2005-02-16 2007-08-27 주식회사 엠디바이오알파 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 약제 조성물
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
EP2494965A3 (de) 2005-04-15 2013-01-02 The Albert Einstein College Of Medicine Of Yeshiva University Vitamin K zur Vorbeugung und Behandlung von zur Behandlung mit Anti-EGF-Rezeptor sekundärem Hautausschlag
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
US8426381B2 (en) * 2005-09-09 2013-04-23 Lucas Meyer Cosmetics Canada Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
EP2249891B1 (de) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
EP2300042A4 (de) 2008-04-30 2012-05-02 Cleveland Clinic Foundation Zusammensetzungen und verfahren zur behandlung von harninkontinenz
JP5819189B2 (ja) * 2009-03-25 2015-11-18 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
WO2013012954A2 (en) * 2011-07-19 2013-01-24 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
CN107580497A (zh) * 2015-02-16 2018-01-12 克桑蒂亚尔 用于预防或治疗皮肤病症的组合物
EP3448421B1 (de) * 2016-04-29 2021-11-03 The Board of Trustees of the Leland Stanford Junior University Verfahren und zusammensetzungen zur vorbeugung und behandlung von chirurgischen verklebungen
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
AU2019310194B2 (en) 2018-07-27 2021-07-22 Arc Medical Devices Inc. Highly purified fucans for the treatment of fibrous adhesions
WO2020176990A1 (en) 2019-03-05 2020-09-10 Arc Medical Devices Inc. Systems and methods for tangential flow filtration of viscous compositions
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用
WO2025166450A1 (en) * 2024-02-05 2025-08-14 ARC Medical Inc. Compositions, devices, systems and methods relating to improvement of range of motion in joints

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
JPS58147064A (ja) 1982-02-25 1983-09-01 Fuji Electric Co Ltd トランジスタ
EP0293826A3 (de) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
AU6285999A (en) * 1998-10-02 2000-04-26 Genzyme Corporation Prevention of adhesions
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Also Published As

Publication number Publication date
CN1319540C (zh) 2007-06-06
DE60223262T2 (de) 2008-08-14
NZ547609A (en) 2008-07-31
CA2458853C (en) 2010-10-19
MXPA04001876A (es) 2004-06-15
CA2458853A1 (en) 2003-03-06
KR20040032992A (ko) 2004-04-17
KR100910246B1 (ko) 2009-07-31
US20050119216A1 (en) 2005-06-02
NZ532015A (en) 2006-12-22
AU2002325113B2 (en) 2006-10-26
US7163930B2 (en) 2007-01-16
DK1420801T3 (da) 2008-03-03
US20050074496A1 (en) 2005-04-07
JP2009280597A (ja) 2009-12-03
JP2005508893A (ja) 2005-04-07
US20030064958A1 (en) 2003-04-03
DE60223262D1 (de) 2007-12-13
EP1420801B1 (de) 2007-10-31
WO2003018033A1 (en) 2003-03-06
JP4758063B2 (ja) 2011-08-24
PT1420801E (pt) 2008-01-17
HK1066482A1 (en) 2005-03-24
CN101028283A (zh) 2007-09-05
US6812220B2 (en) 2004-11-02
EP1420801A1 (de) 2004-05-26
KR20090019926A (ko) 2009-02-25
CN1547478A (zh) 2004-11-17
ES2295386T3 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
GEP20063805B (en) Alkyne-Arylnaphthyridin-4-one as Phosphodiesterase-4 Inhibitors
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
SE0302304D0 (sv) Novel compounds
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
MXPA05007715A (es) Derivados de carboxamida y uso de los mismos como inhibidores del factor xa.
ATE410235T1 (de) Behandlung von ballastwasser
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
MY140194A (en) Novel fusidic acid derivatives
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1420801

Country of ref document: EP